patent/UA-80426-C2

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36
filingDate	2002-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2007-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	UA-80426-C2
titleOfInvention	Pharmaceutical composition comprising arsenite for the treatment of malignancy
abstract	The invention relates to a pharmaceutical composition for the treatment of a solid malignancy chosen from the group consisting of colon tumour, gastric tumour, mammary tumour, ovarian tumour, prostate tumour, and renal tumour, said composition comprising a salt of meta-arsenite (AsO2-) and a pharmaceutically acceptable auxiliary. The invention also relates to its use and to a method of treatment.
priorityDate	2002-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID544 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584777

Total number of triples: 19.